{
    "clinical_study": {
        "@rank": "105868", 
        "acronym": "TRIHEP2", 
        "arm_group": {
            "arm_group_label": "1", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this project is to study the efficacy of an anaplerotic treatment on brain\n      energy profile evolution at an early stage of the Huntington disease."
        }, 
        "brief_title": "Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Huntington Disease", 
        "condition_browse": {
            "mesh_term": "Huntington Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  5 < UHDRS < 50\n\n          -  Age > 18 years\n\n          -  Ability to undergo MR scanning\n\n          -  Covered by french social security\n\n        Exclusion Criteria:\n\n          -  Evidence of psychiatric disorder\n\n          -  Attendant neurological disorder\n\n          -  Contraindications to MRI (claustrophobia, metallic or material implants)\n\n          -  Severe head injury\n\n          -  Unable to understand the protocol\n\n          -  Pregnancy\n\n          -  Failure to give informed consent\n\n          -  Subjects with exclusion criteria required by french law (e.g. subjects who require a\n             legally authorized representative to obtain consent)\n\n          -  Unwillingness to be informed in case of abnormal MRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01882062", 
            "org_study_id": "C12-62"
        }, 
        "intervention": {
            "arm_group_label": "1", 
            "intervention_name": "triheptanoin oil", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75013"
                }, 
                "name": "Brain and Spine Institute"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes and National Agency for Medication Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Ratio of Inorganic Phosphate (Pi) over phosphocreatine (PCr): Pi/PCr", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01882062"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Correlating an improvement of brain energy profile with clinical parameters in Huntington patients such as the Unified Huntington's disease rating scale (UHDRS) and total functional capacity score (TFC).", 
            "measure": "Correlation between primary outcome measure and clinical parameters", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}